LA JOLLA, Calif. (PRWEB) May 22, 2012
Today, CHI-California Healthcare Institute announced the speakers and agenda for its upcoming event dedicated to cancer research and public health policy, “California: Uniting Science & Policy to Advance Cancer Care.”
In 2012, nearly 144,800 Californians will be diagnosed with cancer, according to the California Department of Public Health. This is equivalent to more than 16 new cases every hour of every day. This year alone, nearly 55,415 people will die of the disease — about 150 people each day — and one out of every four deaths in California is attributable to cancer. California is also home to many internationally-renowned oncology research institutions, active and respected patient advocacy groups, as well as companies that are developing the next generation of oncology treatments, with 253 products in the pipeline addressing the second leading cause of death in the state.
The event, which will take place Thursday, July 12, at USC’s Ackerman Grand Ballroom in Los Angeles, will bring together entrepreneurs, investors, healthcare providers, policy experts, patient advocates, member of the media and leaders from California’s biomedical industry and academic research community to discuss the latest oncology research and policies that help or hinder innovation in the field. The discussion will engage local, state and federal legislators on the progress to cure cancer as well as the limits on innovation.
Molly Coye, chief innovation officer of the UCLA Health System, will provide welcome remarks. Dana Goldman, Ph.D., a nationally-recognized health economist influential in both academic and policy circles, will provide the event’s keynote luncheon address. Goldman is a health policy advisor to the Congressional Budget Office and is a frequent speaker on healthcare issues. He serves as a professor and the Norman Topping Chair in Medicine and Public Policy at the University of Southern California. He is also an adjunct professor of health services and radiology at UCLA.
- The State of Cancer Research in the Golden State
Moderator: Dr. Roy Baynes, Senior Vice President, Oncology Therapeutics, Gilead Sciences
Dr. Robert Figlin, Associate Director Academic Development Program, Director Division of Hematology/Oncology, Cedars Sinai
Ashley Dombkowski, Ph.D., Chief Business Officer, 23andMe
Frank McCormick, Ph.D., Director Helen Diller Family Comprehensive Cancer Center at UCSF, President of the American Association of Cancer Research
- Overcoming Disparities in Clinical Trials Among Minority Patients
Dr. Kenneth Bridges, Senior Medical Director, Onyx Pharmaceuticals
- Cancer Transparency: Trying to Move the Dial
Stephanie Teleki, MPH, Ph.D., Senior Program Officer, California HealthCare Foundation
- Improving Access to Advanced Treatment
Margaret Anderson, Executive Director, FasterCures
Kim Popovits, President and CEO, Genomic Health
Bonnie J. Addario, Founder & President, The Bonnie J. Addario Lung Cancer Foundation
Judith Gasson, Ph.D., Professor of Medicine and Biological Chemistry, Director, Jonsson Comprehensive Cancer Center, President, Jonsson Cancer Center Foundation
Click here for the latest speaker line-up, agenda and additional event details or to register.
CHI Members $199
Personalized Medicine Coalition, Pasadena Angels, and LAVA members $279
Academic/Non-Profit Organizations $99
Room Reservation Information
CHI has reserved a block of rooms at The W Hotel. The deadline to receive the negotiated rate of $299 is Friday, June 15. Please click here or contact the hotel reservation line at 310-208-8765 and provide the California Healthcare Institute name in order to receive the negotiated rate.
For sponsorship opportunities please contact Molly Ingraham, CHI's vice president of business development (858-456-8884 or Ingraham(at)chi(dot)org).
Contact CHI Communications Specialist Heather Chambers (Chambers(at)chi(dot)org or 858-456-8885) to register for the event as a member of the media. The Twitter hashtag for the event is #CHIcancercare.
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.